PT - JOURNAL ARTICLE AU - Requena, Francisco AU - Abdallah, Hamza Hadj AU - García, Alejandro AU - Nitschké, Patrick AU - Romana, Sergi AU - Malan, Valérie AU - Rausell, Antonio TI - CNVxplorer: a web tool to assist clinical interpretation of CNVs in rare disease patients AID - 10.1101/2021.03.19.21253806 DP - 2021 Jan 01 TA - medRxiv PG - 2021.03.19.21253806 4099 - http://medrxiv.org/content/early/2021/03/20/2021.03.19.21253806.short 4100 - http://medrxiv.org/content/early/2021/03/20/2021.03.19.21253806.full AB - Copy Number Variants (CNVs) are an important cause of rare diseases. Array-based Comparative Genomic Hybridization tests yield a ∼12% diagnostic rate, with ∼8% of patients presenting CNVs of unknown significance. CNVs interpretation is particularly challenging on genomic regions outside of those overlapping with previously reported structural variants or disease-associated genes. Recent studies showed that a more comprehensive evaluation of CNV features, leveraging both coding and non-coding impacts can significantly improve diagnostic rates. However, currently available CNV interpretation tools are mostly gene-centric or provide only non-interactive annotations difficult to assess in the clinical practice. Here we present CNVxplorer, a web server suited for the functional assessment of CNVs in a clinical diagnostic setting. CNVxplorer mines a comprehensive set of clinical, genomic, and epigenomic features associated with CNVs. It provides sequence constraint metrics, impact on regulatory elements and topologically associating domains, as well as expression patterns. Analyses offered cover (a) agreement with patient phenotypes; (b) visualizations of associations among genes, regulatory elements and transcription factors; (c) enrichment on functional and pathway annotations; and (d) co-occurrence of terms across PubMed publications related to the query CNVs. A flexible evaluation workflow allows dynamic re-interrogation in clinical sessions. CNVxplorer is publicly available at http://cnvxplorer.comCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThe Laboratory of Clinical Bioinformatics was partly supported by the French National Research Agency (ANR) Investissements d Avenir Program (Grant ANR-10-IAHU-01 and ANR-17-RHUS-0002 - CIL-LICO project), by the MSD Avenir fund (Devo-Decode project) and by Christian Dior Couture, Dior. FR is supported by a PhD fellowship from the Fondation Bettencourt-Schueller.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCNVxplorer is publicly available at http://cnvxplorer.com. Detailed tutorials, comprehensive documentation, and a Frequently Asked Questions section are provided. The tool is free and open to all users and there is no login requirement. CNVxplorer code and instructions to deploy a local Docker image are available at https://github.com/RausellLab/cnvxplorer, under a GNU General Public License v3.0. http://cnvxplorer.com https://github.com/RausellLab/cnvxplorer